{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T01:48:06Z","timestamp":1791337686672,"version":"4.3.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T00:00:00Z","timestamp":1724803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T00:00:00Z","timestamp":1724803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Scientific Research Projects from Wuhan Municipal Health Commission","award":["WX23Q27"],"award-info":[{"award-number":["WX23Q27"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-70281-1","type":"journal-article","created":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T21:02:12Z","timestamp":1724878932000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Comprehensive evaluation of the mechanism of human adipose mesenchymal stem cells ameliorating liver fibrosis by transcriptomics and metabolomics analysis"],"prefix":"10.1038","volume":"14","author":[{"given":"Guibao","family":"Ji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zilong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinze","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuxia","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erlei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanjiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,28]]},"reference":[{"key":"70281_CR1","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","volume":"70","author":"SK Asrani","year":"2019","unstructured":"Asrani, S. K., Devarbhavi, H., Eaton, J. & Kamath, P. S. Burden of liver diseases in the world. J. Hepatol. 70, 151\u2013171. https:\/\/doi.org\/10.1016\/j.jhep.2018.09.014 (2019).","journal-title":"J. Hepatol."},{"key":"70281_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1172\/jci200524282","volume":"115","author":"R Bataller","year":"2005","unstructured":"Bataller, R. & Brenner, D. A. Liver fibrosis. J. Clin. Investig. 115, 209\u2013218. https:\/\/doi.org\/10.1172\/jci200524282 (2005).","journal-title":"J. Clin. Investig."},{"key":"70281_CR3","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s40139-013-0019-6","volume":"1","author":"JX Jiang","year":"2013","unstructured":"Jiang, J. X. & Torok, N. J. Liver injury and the activation of the hepatic myofibroblasts. Curr. Pathobiol. Rep. 1, 215\u2013223. https:\/\/doi.org\/10.1007\/s40139-013-0019-6 (2013).","journal-title":"Curr. Pathobiol. Rep."},{"key":"70281_CR4","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.addr.2017.05.018","volume":"121","author":"G Mazza","year":"2017","unstructured":"Mazza, G., Al-Akkad, W. & Rombouts, K. Engineering in vitro models of hepatofibrogenesis. Adv. Drug Deliv. Rev. 121, 147\u2013157. https:\/\/doi.org\/10.1016\/j.addr.2017.05.018 (2017).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"70281_CR5","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1038\/s41467-018-04336-z","volume":"9","author":"M Asmani","year":"2018","unstructured":"Asmani, M. et al. Fibrotic microtissue array to predict anti-fibrosis drug efficacy. Nat. Commun. 9, 2066. https:\/\/doi.org\/10.1038\/s41467-018-04336-z (2018).","journal-title":"Nat. Commun."},{"key":"70281_CR6","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1002\/lt.22228","volume":"17","author":"P Dutkowski","year":"2011","unstructured":"Dutkowski, P. et al. The model for end-stage liver disease allocation system for liver transplantation saves lives, but increases morbidity and cost: A prospective outcome analysis. Liver Transplant. 17, 674\u2013684. https:\/\/doi.org\/10.1002\/lt.22228 (2011).","journal-title":"Liver Transplant."},{"key":"70281_CR7","doi-asserted-by":"publisher","first-page":"400","DOI":"10.15283\/ijsc18143","volume":"12","author":"D Sabry","year":"2019","unstructured":"Sabry, D., Mohamed, A., Monir, M. & Ibrahim, H. A. The effect of mesenchymal stem cells derived microvesicles on the treatment of experimental CCL4 induced liver fibrosis in rats. Int. J. Stem Cells 12, 400\u2013409. https:\/\/doi.org\/10.15283\/ijsc18143 (2019).","journal-title":"Int. J. Stem Cells"},{"key":"70281_CR8","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s41232-019-0107-z","volume":"39","author":"A Tsuchiya","year":"2019","unstructured":"Tsuchiya, A. et al. Mesenchymal stem cell therapies for liver cirrhosis: MSCs as \u201cconducting cells\u201d for improvement of liver fibrosis and regeneration. Inflamm. Regen. 39, 18. https:\/\/doi.org\/10.1186\/s41232-019-0107-z (2019).","journal-title":"Inflamm. Regen."},{"key":"70281_CR9","doi-asserted-by":"publisher","first-page":"562","DOI":"10.21037\/atm.2020.02.119","volume":"8","author":"Y Cao","year":"2020","unstructured":"Cao, Y., Ji, C. & Lu, L. Mesenchymal stem cell therapy for liver fibrosis\/cirrhosis. Ann. Transl. Med. 8, 562. https:\/\/doi.org\/10.21037\/atm.2020.02.119 (2020).","journal-title":"Ann. Transl. Med."},{"key":"70281_CR10","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1007\/s12072-021-10199-2","volume":"15","author":"M Shi","year":"2021","unstructured":"Shi, M. et al. Mesenchymal stem cell therapy in decompensated liver cirrhosis: A long-term follow-up analysis of the randomized controlled clinical trial. Hepatol. Int. 15, 1431\u20131441. https:\/\/doi.org\/10.1007\/s12072-021-10199-2 (2021).","journal-title":"Hepatol. Int."},{"key":"70281_CR11","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1002\/biof.1374","volume":"43","author":"V Volarevic","year":"2017","unstructured":"Volarevic, V. et al. Mesenchymal stem cell-derived factors: Immuno-modulatory effects and therapeutic potential. Biofactors 43, 633\u2013644. https:\/\/doi.org\/10.1002\/biof.1374 (2017).","journal-title":"Biofactors"},{"key":"70281_CR12","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.trim.2013.08.004","volume":"29","author":"M Koch","year":"2013","unstructured":"Koch, M. et al. Isogeneic MSC application in a rat model of acute renal allograft rejection modulates immune response but does not prolong allograft survival. Transplant Immunol. 29, 43\u201350. https:\/\/doi.org\/10.1016\/j.trim.2013.08.004 (2013).","journal-title":"Transplant Immunol."},{"key":"70281_CR13","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1177\/0963689719884885","volume":"28","author":"K-C Huang","year":"2019","unstructured":"Huang, K.-C. et al. Transplantation with GXHPC1 for liver cirrhosis: Phase 1 trial. Cell Transplant. 28, 100\u2013111. https:\/\/doi.org\/10.1177\/0963689719884885 (2019).","journal-title":"Cell Transplant."},{"key":"70281_CR14","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.pharmthera.2023.108563","volume":"253","author":"P Yadav","year":"2024","unstructured":"Yadav, P. et al. Therapeutic potential of stem cells in regeneration of liver in chronic liver diseases: Current perspectives and future challenges. Pharmacol. Therap. 253, 563. https:\/\/doi.org\/10.1016\/j.pharmthera.2023.108563 (2024).","journal-title":"Pharmacol. Therap."},{"key":"70281_CR15","doi-asserted-by":"publisher","first-page":"4670","DOI":"10.1371\/journal.pone.0114670","volume":"9","author":"CM Rodriguez-Ortigosa","year":"2014","unstructured":"Rodriguez-Ortigosa, C. M. et al. Hepatocyte growth factor gene-modified adipose-derived mesenchymal stem cells ameliorate radiation induced liver damage in a rat model. PLoS ONE 9, 4670. https:\/\/doi.org\/10.1371\/journal.pone.0114670 (2014).","journal-title":"PLoS ONE"},{"key":"70281_CR16","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.jconrel.2020.01.042","volume":"320","author":"HS Han","year":"2020","unstructured":"Han, H. S. et al. Human adipose stem cell-derived extracellular nanovesicles for treatment of chronic liver fibrosis. J. Control Release 320, 328\u2013336. https:\/\/doi.org\/10.1016\/j.jconrel.2020.01.042 (2020).","journal-title":"J. Control Release"},{"key":"70281_CR17","doi-asserted-by":"publisher","first-page":"150","DOI":"10.3389\/fcell.2018.00150","volume":"6","author":"W Hou","year":"2018","unstructured":"Hou, W. & Syn, W. K. Role of metabolism in hepatic stellate cell activation and fibrogenesis. Front. Cell Dev. Biol. 6, 150. https:\/\/doi.org\/10.3389\/fcell.2018.00150 (2018).","journal-title":"Front. Cell Dev. Biol."},{"key":"70281_CR18","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3390\/cells9010024","volume":"9","author":"O Khomich","year":"2019","unstructured":"Khomich, O., Ivanov, A. V. & Bartosch, B. Metabolic hallmarks of hepatic stellate cells in liver fibrosis. Cells 9, 24. https:\/\/doi.org\/10.3390\/cells9010024 (2019).","journal-title":"Cells"},{"key":"70281_CR19","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1136\/gutjnl-2019-320205","volume":"70","author":"M Barcena-Varela","year":"2021","unstructured":"Barcena-Varela, M. et al. Epigenetic mechanisms and metabolic reprogramming in fibrogenesis: Dual targeting of G9a and DNMT1 for the inhibition of liver fibrosis. Gut 70, 388\u2013400. https:\/\/doi.org\/10.1136\/gutjnl-2019-320205 (2021).","journal-title":"Gut"},{"key":"70281_CR20","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/hep.30662","volume":"70","author":"R Liu","year":"2019","unstructured":"Liu, R. et al. Cholangiocyte-derived exosomal long noncoding RNA H19 promotes hepatic stellate cell activation and cholestatic liver fibrosis. Hepatology 70, 1317\u20131335. https:\/\/doi.org\/10.1002\/hep.30662 (2019).","journal-title":"Hepatology"},{"key":"70281_CR21","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/nature21365","volume":"542","author":"T Thomou","year":"2017","unstructured":"Thomou, T. et al. Adipose-derived circulating miRNAs regulate gene expression in other tissues. Nature 542, 450\u2013455. https:\/\/doi.org\/10.1038\/nature21365 (2017).","journal-title":"Nature"},{"key":"70281_CR22","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/s12031-010-9446-6","volume":"44","author":"N Ahmadian Kia","year":"2011","unstructured":"Ahmadian Kia, N. et al. Comparative analysis of chemokine receptor\u2019s expression in mesenchymal stem cells derived from human bone marrow and adipose tissue. J. Mol. Neurosci. 44, 178\u2013185. https:\/\/doi.org\/10.1007\/s12031-010-9446-6 (2011).","journal-title":"J. Mol. Neurosci."},{"key":"70281_CR23","doi-asserted-by":"publisher","first-page":"4858","DOI":"10.1093\/nar\/gkaa232","volume":"48","author":"L Ye","year":"2020","unstructured":"Ye, L. et al. The regulation of acetylation and stability of HMGA2 via the HBXIP-activated Akt\u2013PCAF pathway in promotion of esophageal squamous cell carcinoma growth. Nucleic Acids Res. 48, 4858\u20134876. https:\/\/doi.org\/10.1093\/nar\/gkaa232 (2020).","journal-title":"Nucleic Acids Res."},{"key":"70281_CR24","doi-asserted-by":"publisher","first-page":"837","DOI":"10.3389\/fcimb.2020.553837","volume":"10","author":"C Zhang","year":"2020","unstructured":"Zhang, C. et al. Foundation and clinical evaluation of a new method for detecting SARS-CoV-2 antigen by fluorescent microsphere immunochromatography. Front. Cell. Infect. Microbiol. 10, 837. https:\/\/doi.org\/10.3389\/fcimb.2020.553837 (2020).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"70281_CR25","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1002\/hep.28918","volume":"65","author":"VL Massey","year":"2017","unstructured":"Massey, V. L. et al. The hepatic \u201cmatrisome\u201d responds dynamically to injury: Characterization of transitional changes to the extracellular matrix in mice. Hepatology 65, 969\u2013982. https:\/\/doi.org\/10.1002\/hep.28918 (2017).","journal-title":"Hepatology"},{"key":"70281_CR26","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1089\/scd.2012.0395","volume":"22","author":"T Li","year":"2013","unstructured":"Li, T. et al. Exosomes derived from human umbilical cord mesenchymal stem cells alleviate liver fibrosis. Stem Cells Dev. 22, 845\u2013854. https:\/\/doi.org\/10.1089\/scd.2012.0395 (2013).","journal-title":"Stem Cells Dev."},{"key":"70281_CR27","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.bbrc.2018.11.189","volume":"508","author":"L Jiang","year":"2019","unstructured":"Jiang, L. et al. Exosomes derived from human umbilical cord mesenchymal stem cells alleviate acute liver failure by reducing the activity of the NLRP3 inflammasome in macrophages. Biochem. Biophys. Res. Commun. 508, 735\u2013741. https:\/\/doi.org\/10.1016\/j.bbrc.2018.11.189 (2019).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"70281_CR28","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1136\/gutjnl-2020-323014","volume":"71","author":"Z Xie","year":"2022","unstructured":"Xie, Z. et al. Exosome-delivered CD44v6\/C1QBP complex drives pancreatic cancer liver metastasis by promoting fibrotic liver microenvironment. Gut 71, 568\u2013579. https:\/\/doi.org\/10.1136\/gutjnl-2020-323014 (2022).","journal-title":"Gut"},{"key":"70281_CR29","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/hep.29115","volume":"66","author":"DJT Bruden","year":"2017","unstructured":"Bruden, D. J. T. et al. Risk of end-stage liver disease, hepatocellular carcinoma, and liver-related death by fibrosis stage in the hepatitis C Alaska Cohort. Hepatology 66, 37\u201345. https:\/\/doi.org\/10.1002\/hep.29115 (2017).","journal-title":"Hepatology"},{"key":"70281_CR30","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/s41467-017-02725-4","volume":"9","author":"L Deng","year":"2018","unstructured":"Deng, L. et al. Double-layered protein nanoparticles induce broad protection against divergent influenza A viruses. Nat. Commun. 9, 359. https:\/\/doi.org\/10.1038\/s41467-017-02725-4 (2018).","journal-title":"Nat. Commun."},{"key":"70281_CR31","doi-asserted-by":"publisher","first-page":"131103","DOI":"10.1016\/j.foodchem.2021.131103","volume":"371","author":"Q Huang","year":"2022","unstructured":"Huang, Q. et al. Changes in volatile flavor of yak meat during oxidation based on multi-omics. Food Chem. 371, 131103. https:\/\/doi.org\/10.1016\/j.foodchem.2021.131103 (2022).","journal-title":"Food Chem."},{"key":"70281_CR32","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1002\/cphy.c120035","volume":"3","author":"JE Puche","year":"2013","unstructured":"Puche, J. E., Saiman, Y. & Friedman, S. L. Hepatic stellate cells and liver fibrosis. Compr. Physiol. 3, 1473\u20131492. https:\/\/doi.org\/10.1002\/cphy.c120035 (2013).","journal-title":"Compr. Physiol."},{"key":"70281_CR33","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1128\/CMR.00037-16","volume":"30","author":"EM Wilson","year":"2017","unstructured":"Wilson, E. M., Rosenthal, E. S., Kattakuzhy, S., Tang, L. & Kottilil, S. Clinical laboratory testing in the era of directly acting antiviral therapies for hepatitis C. Clin. Microbiol. Rev. 30, 23\u201342. https:\/\/doi.org\/10.1128\/CMR.00037-16 (2017).","journal-title":"Clin. Microbiol. Rev."},{"key":"70281_CR34","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 28, 1947\u20131951. https:\/\/doi.org\/10.1002\/pro.3715 (2019).","journal-title":"Protein Sci."},{"key":"70281_CR35","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27\u201330. https:\/\/doi.org\/10.1093\/nar\/28.1.27 (2000).","journal-title":"Nucleic Acids Res."},{"key":"70281_CR36","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/hep4.1290","volume":"3","author":"L Chen","year":"2019","unstructured":"Chen, L., Brenner, D. A. & Kisseleva, T. Combatting fibrosis: Exosome-based therapies in the regression of liver fibrosis. Hepatol. Commun. 3, 180\u2013192. https:\/\/doi.org\/10.1002\/hep4.1290 (2019).","journal-title":"Hepatol. Commun."},{"key":"70281_CR37","doi-asserted-by":"publisher","first-page":"e346","DOI":"10.1038\/emm.2017.63","volume":"49","author":"G Lou","year":"2017","unstructured":"Lou, G., Chen, Z., Zheng, M. & Liu, Y. Mesenchymal stem cell-derived exosomes as a new therapeutic strategy for liver diseases. Exp. Mol. Med. 49, e346. https:\/\/doi.org\/10.1038\/emm.2017.63 (2017).","journal-title":"Exp. Mol. Med."},{"key":"70281_CR38","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/s13287-019-1310-1","volume":"10","author":"C Hu","year":"2019","unstructured":"Hu, C., Zhao, L. & Li, L. Current understanding of adipose-derived mesenchymal stem cell-based therapies in liver diseases. Stem Cell Res. Ther. 10, 199. https:\/\/doi.org\/10.1186\/s13287-019-1310-1 (2019).","journal-title":"Stem Cell Res. Ther."},{"key":"70281_CR39","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s13287-022-02760-z","volume":"13","author":"Y Hou","year":"2022","unstructured":"Hou, Y. et al. Adipose-derived stem cells alleviate liver injury induced by type 1 diabetes mellitus by inhibiting mitochondrial stress and attenuating inflammation. Stem Cell Res. Ther. 13, 132. https:\/\/doi.org\/10.1186\/s13287-022-02760-z (2022).","journal-title":"Stem Cell Res. Ther."},{"key":"70281_CR40","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1002\/hep.24701","volume":"55","author":"R Urtasun","year":"2012","unstructured":"Urtasun, R. et al. Osteopontin, an oxidant stress sensitive cytokine, up-regulates collagen-I via integrin alpha(V)beta(3) engagement and PI3K\/pAkt\/NFkappaB signaling. Hepatology 55, 594\u2013608. https:\/\/doi.org\/10.1002\/hep.24701 (2012).","journal-title":"Hepatology"},{"key":"70281_CR41","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.jhep.2009.12.007","volume":"52","author":"EL Guimar\u00e3es","year":"2010","unstructured":"Guimar\u00e3es, E. L., Empsen, C., Geerts, A. & van Grunsven, L. A. Advanced glycation end products induce production of reactive oxygen species via the activation of NADPH oxidase in murine hepatic stellate cells. J. Hepatol. 52, 389\u2013397 (2010).","journal-title":"J. Hepatol."},{"key":"70281_CR42","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3346\/jkms.2021.36.e90","volume":"36","author":"J-W Park","year":"2021","unstructured":"Park, J.-W. et al. Increased expression of S100B and RAGE in a mouse model of bile duct ligation-induced liver fibrosis. J. Korean Med. Sci. 36, 90. https:\/\/doi.org\/10.3346\/jkms.2021.36.e90 (2021).","journal-title":"J. Korean Med. Sci."},{"key":"70281_CR43","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.phymed.2024.155337","volume":"125","author":"J Sun","year":"2024","unstructured":"Sun, J. et al. Baicalin and N-acetylcysteine regulate choline metabolism via TFAM to attenuate cadmium-induced liver fibrosis. Phytomedicine 125, 337. https:\/\/doi.org\/10.1016\/j.phymed.2024.155337 (2024).","journal-title":"Phytomedicine"},{"key":"70281_CR44","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1186\/1556-276X-8-236","volume":"8","author":"B Lin","year":"2013","unstructured":"Lin, B. et al. Studies of single-walled carbon nanotubes-induced hepatotoxicity by NMR-based metabonomics of rat blood plasma and liver extracts. Nanoscale Res. Lett. 8, 236. https:\/\/doi.org\/10.1186\/1556-276X-8-236 (2013).","journal-title":"Nanoscale Res. Lett."},{"key":"70281_CR45","doi-asserted-by":"publisher","first-page":"122202","DOI":"10.1016\/j.jchromb.2020.122202","volume":"1152","author":"B Zeng","year":"2020","unstructured":"Zeng, B. et al. Anoectochilus roxburghii polysaccharide prevents carbon tetrachloride-induced liver injury in mice by metabolomic analysis. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 1152, 122202 (2020).","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"70281_CR46","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1111\/jcmm.13170","volume":"21","author":"Y Qu","year":"2017","unstructured":"Qu, Y. et al. Exosomes derived from miR-181-5p-modified adipose-derived mesenchymal stem cells prevent liver fibrosis via autophagy activation. J. Cell. Mol. Med. 21, 2491\u20132502. https:\/\/doi.org\/10.1111\/jcmm.13170 (2017).","journal-title":"J. Cell. Mol. Med."},{"key":"70281_CR47","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.1111\/jcmm.13208","volume":"21","author":"G Lou","year":"2017","unstructured":"Lou, G. et al. MiR-122 modification enhances the therapeutic efficacy of adipose tissue-derived mesenchymal stem cells against liver fibrosis. J. Cell. Mol. Med. 21, 2963\u20132973. https:\/\/doi.org\/10.1111\/jcmm.13208 (2017).","journal-title":"J. Cell. Mol. Med."},{"key":"70281_CR48","doi-asserted-by":"publisher","first-page":"875","DOI":"10.3390\/cells9040875","volume":"9","author":"N Roehlen","year":"2020","unstructured":"Roehlen, N., Crouchet, E. & Baumert, T. F. Liver fibrosis: Mechanistic concepts and therapeutic perspectives. Cells 9, 875. https:\/\/doi.org\/10.3390\/cells9040875 (2020).","journal-title":"Cells"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-70281-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-70281-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-70281-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T21:05:16Z","timestamp":1724879116000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-70281-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,28]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["70281"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-70281-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,28]]},"assertion":[{"value":"4 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20035"}}